ArticlePharmacology research & perspectives2020

Population pharmacokinetic and exposure-response analysis of eptinezumab in the treatment of episodic and chronic migraine.

Brian Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.